Reduction in blood oestrogen from inhibition of aromatase with reduction of oestrogen-dependent cancer cell growth and clinical response25 has clear mechanistic parallels to the reduction in peripheral blood arginine and inhibition of CNS cancer growth achieved by ADI-PEG20. Here, CYP19A1 is linked to central nervous system cancer.